Read about the people who make it all possible at Affimed. Our colleagues share what drives their efforts and how they’re uniting to stop cancer from ever derailing patients’ lives.
There are No Bad Ideas: Conversation is the fuel for innovation
Arndt Schottelius, Chief Scientific Officer of Affimed, shares how his
personal experience fuels the company’s vision to improve
therapeutics for cancer
Learn more about our innovative, groundbreaking approach that leverages the power of the innate immune system to fight cancer.
NK cells: what they are, what they do and why they can offer us hope
Long known for their crucial role in fighting human pathogens, natural killer (NK) cells have been recognized for other exciting tasks in the past years. Especially their role in fighting cancer has gained a lot of interest. The stakes are high: A breakthrough in innate immune-oncology is expected to be a quantum leap in cancer therapy.
Activating the innate immune system to revolutionize the treatment
landscape for patients with CD30-positive lymphomas and EGFR-
expressing solid tumors